NASDAQ: DERM
Journey Medical Corp Stock Ownership - Who owns Journey Medical?

Insider buying vs selling

Have Journey Medical Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Claude MaraouiPresident CEO2025-08-251,250,000$0.07
$81.25kBuy
Claude MaraouiPresident CEO2025-08-2510,877$7.47
$81.25kSell
Ramsey AlloushCOO2025-05-022,857$6.84
$19.54kSell
Joseph BeneschCFO2025-05-022,409$6.84
$16.48kSell
Claude MaraouiPresident CEO2025-05-024,834$6.84
$33.06kSell

1 of 1

DERM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DERM insiders and whales buy or sell their stock.

DERM Shareholders

What type of owners hold Journey Medical Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fortress Biotech Inc15.15%4,110,467$28.36MInsider
Claude Maraoui8.80%2,386,713$16.47MInsider
Tang Capital Management LLC6.83%1,854,596$12.80MInstitution
Wasatch Advisors LP4.85%1,316,275$9.08MInstitution
Opaleye Management Inc3.59%975,000$6.73MInstitution
J Goldman Co LP2.94%798,366$5.51MInstitution
Vanguard Group Inc2.82%764,147$5.27MInstitution
Blackrock Inc2.65%719,784$4.97MInstitution
Ramsey Alloush2.03%551,680$3.81MInsider
Millennium Management LLC1.69%457,812$3.16MInstitution

1 of 3

DERM vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DERM40.62%31.12%Net Buying
ACB11.82%0.00%
OGI7.93%0.00%
TKNO13.06%64.11%Net BuyingNet Buying
LFCR49.09%50.91%Net Selling

Journey Medical Stock Ownership FAQ

Who owns Journey Medical?

Journey Medical (NASDAQ: DERM) is owned by 40.62% institutional shareholders, 31.12% Journey Medical insiders, and 28.26% retail investors. Fortress Biotech Inc is the largest individual Journey Medical shareholder, owning 4.11M shares representing 15.15% of the company. Fortress Biotech Inc's Journey Medical shares are currently valued at $28.40M.

If you're new to stock investing, here's how to buy Journey Medical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.